Compugen Ltd.
CGEN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -16.7% | 346.1% | 25% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 71.5% | 94% | 87% | 88.7% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -51.7% | -37.4% | -441.7% | -576.9% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -51.1% | -56.1% | -449.3% | -570.1% |
| EPS Diluted | -0.16 | -0.21 | -0.39 | -0.41 |
| % Growth | 23.8% | 46.2% | 4.9% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |